Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center
- PMID: 24339153
- DOI: 10.1002/uog.13277
Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center
Abstract
Objective: To review the performance of non-invasive prenatal testing (NIPT) by low-coverage whole-genome sequencing of maternal plasma DNA at a single center.
Methods: The NIPT result and pregnancy outcome of 1982 consecutive cases were reviewed. NIPT was based on low coverage (0.1×) whole-genome sequencing of maternal plasma DNA. All subjects were contacted for pregnancy and fetal outcome.
Results: Of the 1982 NIPT tests, a repeat blood sample was required in 23 (1.16%). In one case, a conclusive report could not be issued, probably because of an abnormal vanished twin fetus. NIPT was positive for common trisomies in 29 cases (23 were trisomy 21, four were trisomy 18 and two were trisomy 13); all were confirmed by prenatal karyotyping (specificity=100%). In addition, 11 cases were positive for sex-chromosomal abnormalities (SCA), and nine cases were positive for other aneuploidies or deletion/duplication. Fourteen of these 20 subjects agreed to undergo further investigations, and the abnormality was found to be of fetal origin in seven, confined placental mosaicism (CPM) in four, of maternal origin in two and not confirmed in one. Overall, 85.7% of the NIPT-suspected SCA were of fetal origin, and 66.7% of the other abnormalities were caused by CPM. Two of the six cases suspected or confirmed to have CPM were complicated by early-onset growth restriction requiring delivery before 34 weeks. Fetal outcome of the NIPT-negative cases was ascertained in 1645 (85.15%). Three chromosomal abnormalities were not detected by NIPT, including one case each of a balanced translocation, unbalanced translocation and triploidy. There were no known false negatives involving the common trisomies (sensitivity=100%).
Conclusions: Low-coverage whole-genome sequencing of maternal plasma DNA was highly accurate in detecting common trisomies. It also enabled the detection of other aneuploidies and structural chromosomal abnormalities with high positive predictive value.
Keywords: NIPT; aneuploidy; chromosomal deletions; chromosomal duplications; fetal DNA; next-generation sequencing; sex chromosomal abnormality; whole genome.
Copyright © 2013 ISUOG. Published by John Wiley & Sons Ltd.
Comment in
-
Re: Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. T. K. Lau, S. W. Cheung, P. S. S. Lo, A. N. Pursley, M. K. Chan, F. Jiang, H. Zhang, W. Wang, L. F. J. Jong, O. K. C. Yuen, H. Y. C. Chan, W. S. K. Chan and K. W. Choy. Ultrasound Obstet Gynecol 2014; 43: 254-264.Ultrasound Obstet Gynecol. 2014 Mar;43(3):245. doi: 10.1002/uog.13314. Ultrasound Obstet Gynecol. 2014. PMID: 24591230 No abstract available.
Similar articles
-
Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.Ultrasound Obstet Gynecol. 2015 May;45(5):530-8. doi: 10.1002/uog.14792. Epub 2015 Apr 8. Ultrasound Obstet Gynecol. 2015. PMID: 25598039
-
Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.Am J Obstet Gynecol. 2017 Dec;217(6):691.e1-691.e6. doi: 10.1016/j.ajog.2017.10.005. Epub 2017 Oct 13. Am J Obstet Gynecol. 2017. PMID: 29032050
-
Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service.Prenat Diagn. 2013 Jun;33(6):602-8. doi: 10.1002/pd.4076. Epub 2013 Apr 2. Prenat Diagn. 2013. PMID: 23553438
-
[Combined first trimester screening and cell-free fetal DNA - “next generation screening”].Ultraschall Med. 2014 Jun;35(3):229-36. doi: 10.1055/s-0034-1366353. Epub 2014 Apr 24. Ultraschall Med. 2014. PMID: 24764214 Review. German.
-
Non-invasive prenatal testing for aneuploidy: current status and future prospects.Ultrasound Obstet Gynecol. 2013 Jul;42(1):15-33. doi: 10.1002/uog.12513. Ultrasound Obstet Gynecol. 2013. PMID: 23765643 Review.
Cited by
-
Noninvasive Prenatal Testing - When Is It Advantageous to Apply.Biomed Hub. 2017 Mar 4;2(1):1-11. doi: 10.1159/000458432. eCollection 2017 Jan-Apr. Biomed Hub. 2017. PMID: 31988902 Free PMC article. Review.
-
Statistical Approach to Decreasing the Error Rate of Noninvasive Prenatal Aneuploid Detection caused by Maternal Copy Number Variation.Sci Rep. 2015 Nov 4;5:16106. doi: 10.1038/srep16106. Sci Rep. 2015. PMID: 26534864 Free PMC article.
-
Systematic Review of Accuracy Differences in NIPT Methods for Common Aneuploidy Screening.J Clin Med. 2025 Apr 18;14(8):2813. doi: 10.3390/jcm14082813. J Clin Med. 2025. PMID: 40283645 Free PMC article. Review.
-
Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management.Eur J Hum Genet. 2015 Oct;23(10):1286-93. doi: 10.1038/ejhg.2014.282. Epub 2015 Jan 14. Eur J Hum Genet. 2015. PMID: 25585704 Free PMC article.
-
Next Generation Sequencing Based Non-invasive Prenatal Testing (NIPT): First Report From Saudi Arabia.Front Genet. 2021 Feb 4;12:630787. doi: 10.3389/fgene.2021.630787. eCollection 2021. Front Genet. 2021. PMID: 33613643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical